Pai-Chi Teng

9PUBLICATIONS
49CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsSustainable architectureGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 27, 2026
A Programmed Cell Death Protein 1 Pathway-Derived Prognostic Transcriptomic Signature in Bladder Cancer: Development in TCGA-BLCA and Evaluation in Independent Cohorts.

|Mar 10, 2025
Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity That Associate with a Clinically Aggressive Subtype of Prostate Cancer.

Le Zhang, Pai-Chi Teng, Karen A Cavassani

|Dec 19, 2022
Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease.

Pai-Chi Teng, Daniel Q Huang, Ting-Yi Lin

|Oct 17, 2022
Superrepellent Doubly Reentrant Geometry Promotes Antibiofouling and Prevention of Coronavirus Contamination.

Meng-Shiue Lee, Yueh Chien, Pai-Chi Teng

|May 11, 2022
Circulating tumor cells: A step toward precision medicine in hepatocellular carcinoma.

Pai-Chi Teng, Vatche G Agopian, Ting-Yi Lin

|Mar 25, 2022
Identification of a Steroid Hormone-Associated Gene Signature Predicting the Prognosis of Prostate Cancer through an Integrative Bioinformatics Analysis.

Yo-Liang Lai, Chia-Hsin Liu, Shu-Chi Wang

Pageof 2

Frequent Collaborators

3 joint publications

Ting-Yi Lin

3 joint publications

Chia-Yang Li

3 joint publications

Hsin-Chih Yeh

3 joint publications

Shu-Chi Wang